Frassetto LA - Search Results

1

Meal Effects Confound Attempts to Counteract Rabeprazole-Induced Hypochlorhydria Decreases in Atazanavir Absorption.

Faber KP, Wu HF, Yago MR, Xu X, Kadiyala P, Frassetto LA, Benet LZ. Faber KP, et al. Among authors: frassetto la. Pharm Res. 2017 Mar;34(3):619-628. doi: 10.1007/s11095-016-2090-2. Epub 2016 Dec 27. Pharm Res. 2017. PMID: 28028768 Free PMC article. Clinical Trial.

2

Higher Renal Net Acid Excretion, but Not Higher Phosphate Excretion, during Childhood and Adolescence Associates with the Circulating Renal Tubular Injury Marker Interleukin-18 in Adulthood.

Derakhshandeh-Rishehri SM, Franco LP, Hua Y, Herder C, Kalhoff H, Frassetto LA, Wudy SA, Remer T. Derakhshandeh-Rishehri SM, et al. Among authors: frassetto la. Int J Mol Sci. 2024 Jan 24;25(3):1408. doi: 10.3390/ijms25031408. Int J Mol Sci. 2024. PMID: 38338685 Free PMC article.

3

The pharmacokinetics and metabolic disposition of tacrolimus: a comparison across ethnic groups.

Mancinelli LM, Frassetto L, Floren LC, Dressler D, Carrier S, Bekersky I, Benet LZ, Christians U. Mancinelli LM, et al. Clin Pharmacol Ther. 2001 Jan;69(1):24-31. doi: 10.1067/mcp.2001.113183. Clin Pharmacol Ther. 2001. PMID: 11180035 Clinical Trial.

4

Pharmacogenomics and transplantation: where are we?

Frassetto LA, Benet LZ. Frassetto LA, et al. Am J Transplant. 2004 Jun;4(6):843. doi: 10.1111/j.1600-6143.2004.00471.x. Am J Transplant. 2004. PMID: 15147415 Free article. No abstract available.

5

Effects of uremic toxins on hepatic uptake and metabolism of erythromycin.

Sun H, Huang Y, Frassetto L, Benet LZ. Sun H, et al. Drug Metab Dispos. 2004 Nov;32(11):1239-46. doi: 10.1124/dmd.104.000521. Epub 2004 Jul 30. Drug Metab Dispos. 2004. PMID: 15286055

6

Pharmacokinetic interactions between cyclosporine and protease inhibitors in HIV+ subjects.

Frassetto L, Thai T, Aggarwal AM, Bucher P, Jacobsen W, Christians U, Benet LZ, Floren LC. Frassetto L, et al. Drug Metab Pharmacokinet. 2003;18(2):114-20. doi: 10.2133/dmpk.18.114. Drug Metab Pharmacokinet. 2003. PMID: 15618725 Free article.

7

Cyclosporine pharmacokinetics and dosing modifications in human immunodeficiency virus-infected liver and kidney transplant recipients.

Frassetto L, Baluom M, Jacobsen W, Christians U, Roland ME, Stock PG, Carlson L, Benet LZ. Frassetto L, et al. Transplantation. 2005 Jul 15;80(1):13-7. doi: 10.1097/01.tp.0000165111.09687.4e. Transplantation. 2005. PMID: 16003227

8

Effects of renal failure on drug transport and metabolism.

Sun H, Frassetto L, Benet LZ. Sun H, et al. Pharmacol Ther. 2006 Jan;109(1-2):1-11. doi: 10.1016/j.pharmthera.2005.05.010. Epub 2005 Aug 8. Pharmacol Ther. 2006. PMID: 16085315 Review.

9

Effects of short-term alendronate on bone mineral density in haemodialysis patients.

Wetmore JB, Benet LZ, Kleinstuck D, Frassetto L. Wetmore JB, et al. Nephrology (Carlton). 2005 Aug;10(4):393-9. doi: 10.1111/j.1440-1797.2005.00436.x. Nephrology (Carlton). 2005. PMID: 16109088 Clinical Trial.

10

Liquid chromatographic tandem mass spectrometric assay for the uremic toxin 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid in human plasma.

Huang Y, Sun H, Frassetto L, Benet LZ, Lin ET. Huang Y, et al. Rapid Commun Mass Spectrom. 2006;20(10):1611-4. doi: 10.1002/rcm.2479. Rapid Commun Mass Spectrom. 2006. PMID: 16628600 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters